Trademark: 88425716
Word
CHAMPLAIN
Status
Registered
Status Code
700
Status Date
Tuesday, August 18, 2020
Serial Number
88425716
Registration Number
6127525
Registration Date
Tuesday, August 18, 2020
Mark Type
4000
Filing Date
Friday, May 10, 2019
Published for Opposition
Tuesday, June 2, 2020

Trademark Owner History
Aphria Inc. - Original Registrant

Classifications
29 Oils derived from hemp for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; hemp related products, namely, oils for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; food products containing hemp, resins, and oils, namely, butter; fruit based energy food bars; seed and nut-based energy food bars; processed edible hemp seeds; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD
5 Medicated bath salts; medicated liquid soaps; disinfectant and anti-bacterial liquid soaps; medicated skin care preparations; Hemp related products, namely, medicinal oils and salves; concentrated medicated pastes for the teeth and gums, for the hair and scalp, and for use on skin rashes; tinctures, tablets and capsules for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; medicated oils, salves, and concentrated pastes for the treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders, and anxiety; tinctures, tablets and capsules each containing resins and oils derived from hemp for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing derivatives of hemp, namely, resins and oils for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; medicated topical skin creams, medicated bar and liquid soaps; medicated bath additives, namely, bath herbs, bath oils, bath salts; medicated body creams, medicated body oils, medicated face and body lotions, medicated face and body milk, medicated face lotion, and medicated skin care preparations each of the foregoing containing derivatives of hemp for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid; personal sexual lubricants; transdermal patches containing derivatives of hemp for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oral sprays for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; hemp derivatives for medicinal use; hemp related products, namely, oils for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils derived from hemp for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD
34 Smokers' articles, namely, grinders for use with hemp, dried hemp for smoking; derivatives of hemp, namely, processed resins and oils in the nature of liquids for use in electronic cigarettes and oral smokeless vaporizers; e-liquids comprised of hemp derivatives for use in electronic cigarettes and oral smokeless vaporizers for recreational use; smokers' articles, namely, smoking pipes, pouches for use with hemp, lighters for smokers, oral vaporizers for smokers; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD
31 Live hemp plants; hemp seeds for planting and agricultural use; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basis

Trademark Events
Oct 25, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 25, 2021
Teas Change Of Correspondence Received
Oct 25, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 25, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 25, 2021
Teas Change Of Owner Address Received
Aug 18, 2020
Registered-Principal Register
Jun 2, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 2, 2020
Published For Opposition
May 13, 2020
Notification Of Notice Of Publication E-Mailed
Apr 28, 2020
Approved For Pub - Principal Register
Apr 27, 2020
Teas/Email Correspondence Entered
Apr 27, 2020
Correspondence Received In Law Office
Apr 27, 2020
Assigned To Lie
Apr 22, 2020
Teas Response To Office Action Received
Oct 22, 2019
Notification Of Non-Final Action E-Mailed
Oct 22, 2019
Non-Final Action E-Mailed
Oct 22, 2019
Non-Final Action Written
Oct 15, 2019
Assigned To Examiner
May 30, 2019
Assigned To Examiner
May 28, 2019
New Application Office Supplied Data Entered
May 14, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24